Notice: This company has been marked as potentially delisted and may not be actively trading. Celyad Oncology (CYAD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Celyad Oncology to Present at the 2024 SITC Annual MeetingOctober 7, 2024 | finance.yahoo.comCelyad Oncology Announces Appointment of Matt Kane as Chief Executive OfficerSeptember 16, 2024 | finance.yahoo.comCelyad Oncology Reports First Half Year 2024 Financial Results and Recent Business HighlightsSeptember 13, 2024 | finance.yahoo.comCelyad Oncology SA (CYADB.XC)July 19, 2024 | finance.yahoo.comCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | finance.yahoo.comCSBR Champions Oncology, Inc.March 29, 2024 | seekingalpha.comCelyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookJanuary 17, 2024 | finanznachrichten.deCelyad Oncology provides fourth quarter 2023 business update and 2024 outlookJanuary 16, 2024 | finance.yahoo.comCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)December 17, 2023 | businesswire.comCelyad Announces Management ChangeDecember 4, 2023 | finance.yahoo.comInformation on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 MayNovember 14, 2023 | tmcnet.comCelyad Oncology Share Price (CYAD.BR)November 11, 2023 | lse.co.ukCelyad Oncology SA: Celyad Oncology reports third quarter 2023 financial results and recent business highlightsNovember 9, 2023 | finanznachrichten.deCelyad Oncology reports third quarter 2023 financial results and recent business highlightsNovember 9, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology announces the termination of its American Depository Receipt programSeptember 26, 2023 | finanznachrichten.deCelyad Oncology to Terminate ADR ProgramSeptember 25, 2023 | marketwatch.comCelyad Oncology announces the termination of its American Depository Receipt programSeptember 25, 2023 | finance.yahoo.comCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCSeptember 15, 2023 | finance.yahoo.comCelyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SASeptember 12, 2023 | businesswire.comCelyad Oncology SA (CYAD.BR)September 12, 2023 | ca.finance.yahoo.comCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCSeptember 7, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsSeptember 4, 2023 | finanznachrichten.deCelyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsSeptember 4, 2023 | finance.yahoo.comCelyad Oncology (CYADY) Earnings Dates & ReportsSeptember 4, 2023 | investing.comCelyad Oncology Receives Approximately EUR 9.8m in Private Placement Commitments From Historical ShareholdersAugust 29, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersAugust 25, 2023 | finanznachrichten.deCelyad Oncology SA (CYADY)July 19, 2023 | investing.comCelyad Oncology SA: Celyad Oncology announces receipt of Nasdaq delisting noticeMay 16, 2023 | finanznachrichten.deCelyad Oncology Announces Receipt of Nasdaq Delisting NoticeMay 15, 2023 | finance.yahoo.comCelyad plans to delist from Nasdaq amid cash woesMay 5, 2023 | msn.comCelyad Oncology reports first quarter 2023 financial results and recent business highlightsMay 5, 2023 | finance.yahoo.comCelyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From NasdaqMay 5, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid PriceApril 27, 2023 | finanznachrichten.deCelyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid PriceApril 24, 2023 | finance.yahoo.comCelyad Oncology announces receipt of Nasdaq noticeApril 4, 2023 | finance.yahoo.comCelyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call TranscriptMarch 27, 2023 | finance.yahoo.comCelyad Oncology Appoints Georges Rawadi As CEO - Quick FactsMarch 24, 2023 | markets.businessinsider.comCelyad Oncology Appoints Georges Rawadi as Its New CEOMarch 24, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology Reports Full Year 2022 Financial Results and Recent Business HighlightsMarch 23, 2023 | finanznachrichten.deCelyad Oncology reports full year 2022 financial results and recent business highlightsMarch 23, 2023 | finance.yahoo.comCelyad Oncology to Announce Full Year 2022 Financial Results and Host Conference CallMarch 17, 2023 | finance.yahoo.comCelyad slumps ~30% as board to put proposal to continue activities on vote at shareholders' meetMarch 15, 2023 | msn.comCelyad Oncology announces non-cash impairmentMarch 15, 2023 | finance.yahoo.comCelyad Oncology: Letter to ShareholdersMarch 1, 2023 | finance.yahoo.comREPEAT -- Celyad Oncology SA - Letter to ShareholdersMarch 1, 2023 | finance.yahoo.comCelyad Oncology SA - Letter to ShareholdersFebruary 28, 2023 | finance.yahoo.comCelyad Oncology Announces the Publication of Data From Its Phase 1 THINK Study of CYAD-01February 9, 2023 | finance.yahoo.comCelyad Oncology provides fourth quarter 2022 business update and 2023 outlookFebruary 3, 2023 | uk.finance.yahoo.comCelyad Oncology SA (CYAD)January 18, 2023 | ca.finance.yahoo.comThinking about buying stock in Celyad Oncology, Calyxt, IQIYI, Vinco Ventures, or Carvana?January 17, 2023 | benzinga.com Get Celyad Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. CYAD Media Mentions By Week CYAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYAD News Sentiment▼0.000.47▲Average Medical News Sentiment CYAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYAD Articles This Week▼00▲CYAD Articles Average Week Get Celyad Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies InterCure News Celularity News OptiNose News Cellectar Biosciences News Aileron Therapeutics News CervoMed News Aadi Bioscience News Mural Oncology News Theratechnologies News Kezar Life Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYAD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celyad Oncology SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Celyad Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYAD Stock Alerts